1. Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32–8.
2. Hales CM SJ, Martin CB, Kohen D. Prescription drug use among adults aged 40–79 in the United States and Canada. NCHS Data Brief No 347. 2019. https://www.cdc.gov/nchs/products/databriefs/db347.htm#::text=Nearly%207%20in%2010%20adults,and%2018.8%25%20in%20Canada.
3. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.
4. Barclay K, Frasetto A, Robb J, Mandel ED. Polypharmacy in the elderly: how to reduce adverse drug events. Clin Rev. 2018;28(2):38–44.
5. Turgeon J, Michaud V, Steffen L. The dangers of polypharmacy in elderly patients. JAMA Intern Med. 2017;177(10):1544.